Carl L.G. Hansen
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Carl L.G. Hansen
Carl L.G. Hansen was last confirmed as Board Member at AbCellera Biologics Inc. (ABCL) in a filing dated April 29, 2025. The proxy statement of AbCellera Biologics Inc. reports total compensation of $6,293,085 for Carl L.G. Hansen in fiscal 2025, including a base salary of $550,000. Disclosed compensation is on record for 7 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2012-01-01–2025-04-29
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | AbCellera Biologics Inc. (ABCL) | Chief Executive Officer | $550,000 | $6,293,085 |
| 2024 | AbCellera Biologics Inc. (ABCL) | Chief Executive Officer | $460,000 | $8,245,492 |
| 2023 | AbCellera Biologics Inc. (ABCL) | Chief Executive Officer | $460,000 | $714,939 |
| 2022 | AbCellera Biologics Inc. (ABCL) | Chief Executive Officer | $450,000 | $8,797,689 |
| 2021 | AbCellera Biologics Inc. (ABCL) | Chief Executive Officer | $400,000 | $9,116,252 |
| 2020 | AbCellera Biologics Inc. (ABCL) | Chief Executive Officer | $296,155 | $16,962,608 |
| 2019 | AbCellera Biologics Inc. (ABCL) | Chief Executive Officer | $177,381 | $249,898 |
Recent activity
No call appearances or filed executive changes recorded yet.